November 5, 2025 · Form 4 insider transaction
Mates Sharon bought 28,517 shares of BENITEC BIOPHARMA INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026.